Shiquan Shen

PRMT1 mediated methylation of YBX1 promotes tumorigenicity of glioblastoma stem cells

Ji Wang, Shiquan Shen, Dongshan Zhang, Zongyu Xiao et autres

cn (code pays fourni par la source)

PRMT3-mediated arginine methylation of YBX1 promotes tumorigenesis in glioblastoma

Ji Wang, Shiquan Shen, Dongshan Zhang, Honglong Zhou et autres

cn (code pays fourni par la source)

PRMT6 facilitates EZH2 protein stability by inhibiting TRAF6-mediated ubiquitination degradation to promote glioblastoma cell invasion and migration

Ji Wang, Shiquan Shen, Jian You, Zhaotao Wang et autres

Invasion and migration are the key hallmarks of cancer, and aggressive growth is a major factor contributing to treatment failure and poor prognosis in glioblastoma. Protein arginine methyltransferase 6 (PRMT6), as an epigenetic regulator, has been confirmed to promote the malignant proliferation …

cn (code pays fourni par la source)

PRMT6 facilitates EZH2 protein stability by inhibiting TRAF6-mediated ubiquitination degradation to promote glioblastoma cell invasion and migration

Ji Wang, Shiquan Shen, Jian You, Zhaotao Wang et autres

tw, cn (code pays fourni par la source)

PRMT1 in human neoplasm: cancer biology and potential therapeutic target

Shiquan Shen, Honglong Zhou, Zongyu Xiao, Shaofen Zhan et autres

Protein arginine methyltransferase 1 (PRMT1), the predominant type I protein arginine methyltransferase, plays a crucial role in normal biological functions by catalyzing the methylation of arginine side chains, specifically monomethylarginine (MMA) and asymmetric dimethylarginine (ADMA), within proteins. Recent investigations have unveiled an …

cn (code pays fourni par la source)